Viromed Medical AG (Q11) — Free Cash Flow Generation Index
Latest as of December 2024:
-3.82x
Viromed Medical AG (Q11) has a Free Cash Flow Generation Index of -3.82x as of December 2024. Free cash flow of €-28.46 Million represents -4% of operating cash flow (€7.45 Million). See Viromed Medical AG working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
-3.82x
Free Cash Flow / Operating CF
Free Cash Flow
€-28.46 Million
EUR
Operating Cash Flow
€7.45 Million
EUR
Capital Expenditures
€35.91 Million
EUR
Annual Free Cash Flow Generation for Viromed Medical AG (None–None)
Year-by-year Free Cash Flow Generation Index for Viromed Medical AG. For the full company profile including market capitalisation, see Viromed Medical AG (Q11) total market value.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).